Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 22722338)

1.

Metformin pathways: pharmacokinetics and pharmacodynamics.

Gong L, Goswami S, Giacomini KM, Altman RB, Klein TE.

Pharmacogenet Genomics. 2012 Nov;22(11):820-7. doi: 10.1097/FPC.0b013e3283559b22. Review. No abstract available.

2.

Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus.

Sambol NC, Chiang J, O'Conner M, Liu CY, Lin ET, Goodman AM, Benet LZ, Karam JH.

J Clin Pharmacol. 1996 Nov;36(11):1012-21.

PMID:
8973990
3.

The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.

Stocker SL, Morrissey KM, Yee SW, Castro RA, Xu L, Dahlin A, Ramirez AH, Roden DM, Wilke RA, McCarty CA, Davis RL, Brett CM, Giacomini KM.

Clin Pharmacol Ther. 2013 Feb;93(2):186-94. doi: 10.1038/clpt.2012.210. Epub 2012 Oct 17.

4.

Metformin and intestinal glucose handling.

Bailey CJ.

Diabetes Metab Rev. 1995 Sep;11 Suppl 1:S23-32. Review. No abstract available.

PMID:
8529481
5.

Metformin: fifty-two not out.

Campbell IW.

J Indian Med Assoc. 2009 Nov;107(11):779-84. Review. No abstract available.

PMID:
20469782
6.

Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metformin.

Scheen AJ.

Expert Opin Drug Metab Toxicol. 2010 Oct;6(10):1265-76. doi: 10.1517/17425255.2010.513699. Review.

PMID:
20707611
7.

Do thiazide diuretics alter the pharmacokinetics of metformin in patients with type 2 diabetes already established on metformin?

Sung EY, Moore MP, Lunt H, Doogue M, Zhang M, Begg EJ.

Br J Clin Pharmacol. 2009 Jan;67(1):130-1. doi: 10.1111/j.1365-2125.2008.03302.x. Epub 2008 Sep 23. No abstract available.

8.

The target of metformin in type 2 diabetes.

Ferrannini E.

N Engl J Med. 2014 Oct 16;371(16):1547-8. doi: 10.1056/NEJMcibr1409796. No abstract available.

PMID:
25317875
9.

[Antidiabetes drug metformin is a donor of nitric oxide: ESR measurement of efficiency].

Serezhenkov VA, Kuznetsov IS, Romantsova TI, Kuznetsova MI, Vanin AF.

Biofizika. 2011 Nov-Dec;56(6):1125-33. Russian.

PMID:
22279758
10.
11.

Disposition of metformin: variability due to polymorphisms of organic cation transporters.

Zolk O.

Ann Med. 2012 Mar;44(2):119-29. doi: 10.3109/07853890.2010.549144. Epub 2011 Mar 3. Review.

PMID:
21366511
13.

Janumet: a combination product suitable for use in patients with Type 2 diabetes.

Reynolds JK, Neumiller JJ, Campbell RK.

Expert Opin Investig Drugs. 2008 Oct;17(10):1559-65. doi: 10.1517/13543784.17.10.1559 . Review.

PMID:
18808315
14.

Mechanisms of metformin action in non-insulin-dependent diabetes mellitus.

Perriello G.

Diabetes Metab Rev. 1995 Sep;11 Suppl 1:S51-6. Review. No abstract available.

PMID:
8529485
15.

Population PK/PD analysis of metformin using the signal transduction model.

Chae JW, Baek IH, Lee BY, Cho SK, Kwon KI.

Br J Clin Pharmacol. 2012 Nov;74(5):815-23. doi: 10.1111/j.1365-2125.2012.04260.x.

16.

Pioglitazone/metformin.

Deeks ED, Scott LJ.

Drugs. 2006;66(14):1863-77; discussion 1878-80.

PMID:
17040116
17.

Metformin: an alternative treatment for noninsulin-dependent diabetes mellitus.

Hitt CM.

Conn Med. 1995 Dec;59(12):727-30. No abstract available.

PMID:
8821636
18.

Mysterious metformin.

Chong CR, Chabner BA.

Oncologist. 2009 Dec;14(12):1178-81. doi: 10.1634/theoncologist.2009-0286. Epub 2009 Dec 10. No abstract available.

19.

[Metformin and type-2 diabetes mellitus].

Mata Cases M.

Aten Primaria. 2008 Mar;40(3):147-53. Review. Spanish. No abstract available.

PMID:
18373928
20.

Revisiting the mechanisms of metformin action in the liver.

Viollet B, Foretz M.

Ann Endocrinol (Paris). 2013 May;74(2):123-9. doi: 10.1016/j.ando.2013.03.006. Epub 2013 Apr 10. Review.

PMID:
23582849
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk